A
Advanced Enzyme Tech
ADVENZYMES Share Price
Healthcare307.40
as on 17 Apr 2026 at 15:44
Market Cap
₹3,441 Cr
PE Ratio
22.10
ROCE
12.52%
ADVENZYMES Fundamentals
Company Valuation
Market Cap (₹ Cr.)
3,441
PE Ratio
22.10
PB Ratio
2.31
Dividend Yield
1.31%
ROE
9.12%
ROCE
12.52%
Book Value (₹)
132.64
Face Value (₹)
2.00
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 43.08% | 43.08% | 43.07% | 43.04% | 43.26% |
| Domestic Institutional Investors (DII) | 8.19% | 8.45% | 6.41% | 5.51% | 5.41% |
| Foreign Institutional Investors (FII) | 11.90% | 23.46% | 25.41% | 25.86% | 25.49% |
| Public Investors | 16.68% | 16.92% | 16.95% | 17.44% | 17.57% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
ADVENZYMES Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Biotechnology
Company Classification
Microcap
BSE Scrip Code
540025
NSE Scrip Name
ADVENZYMES
ISIN
INE837H01020



